HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ganoderma lucidum polysaccharides peptide inhibits the growth of vascular endothelial cell and the induction of VEGF in human lung cancer cell.

Abstract
Ganoderma lucidum Polysaccharide Peptide (Gl-PP) has shown some effects as anti-tumors in mice and potential anti-angiogenesis. In this study, we elucidated the possible mechanism of Gl-PP action on anti-angiogenesis of tumor. Our research indicated that the proliferation of HUVECs was inhibited by Gl-PP in a dose-dependent fashion, but not because of cytotoxicity. Flow cytometric studies revealed that Gl-PP treatment of HUVECs could induce cell apoptosis directly. Moreover, addition of Gl-PP also led to a reduction of Bcl-2 anti-apoptotic protein expression and an increase of Bax pro-apoptotic protein expression of HUVECs. Therefore, inducing cell apoptosis by Gl-PP might be the mechanism of inhibiting HUVEC proliferation. Human lung carcinoma cells PG when exposed to high dose of Gl-PP in hypoxia for 18 h resulted in a decrease in the secreted VEGF. Taken together, these findings support the hypothesis that the key attribute of the anti-angiogenic potential of Gl-PP is that it may directly inhibit vascular endothelial cell proliferation or indirectly decrease growth factor expression of tumor cells.
AuthorsQi-zhen Cao, Zhi-Bin Lin
JournalLife sciences (Life Sci) Vol. 78 Issue 13 Pg. 1457-63 (Feb 23 2006) ISSN: 0024-3205 [Print] Netherlands
PMID16269156 (Publication Type: Journal Article)
Chemical References
  • Drugs, Chinese Herbal
  • Polysaccharides
  • Vascular Endothelial Growth Factor A
Topics
  • Apoptosis (drug effects)
  • Cell Division (drug effects)
  • Cell Survival (drug effects)
  • Cells, Cultured
  • Drugs, Chinese Herbal (pharmacology)
  • Endothelium, Vascular (cytology, drug effects)
  • Flow Cytometry
  • Ganoderma
  • Humans
  • Lung Neoplasms
  • Polysaccharides (pharmacology)
  • Reishi
  • Tumor Cells, Cultured
  • Umbilical Veins
  • Vascular Endothelial Growth Factor A (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: